Skip to main content
Phase 3 fails to demonstrate survival benefit with tipifarnib maintenance in AML in remission
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Phase 3 fails to demonstrate survival benefit with tipifarnib maintenance in AML in remission
User login
Username
Password
Reset your password
Type
Lead
score